You et al found that vasoactive peptide urotensin II receptor antagonist can cause hyperlipidemia and decrease mTOR and Kyung et al showed that phosphatase and tensin homolog (PTEN) inactivation may have relationship with activation of the PI3K/Akt signaling pathway [22], [23]. The gene discussed is MTOR; the disease is hyperlipidemia.